window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 10, 2026

  • News
  • About Us
Contact Us

advanced therapies

  • Biotech,Cell & Gene Therapy,Drug Development,Events and Conferences

    ELRIG announces keynotes for inaugural Cell and Gene Therapy 2026 conference

    ELRIG has unveiled the keynote speakers for its inaugural Cell [...]

    January 26, 2026
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    September 23, 2025
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding

    Vitalant and UPMC expand partnership to advance cell and gene therapy initiatives

    Vitalant, a national blood and biotherapies provider, is expanding its [...]

    September 8, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Patient Centricity,Technology and platforms

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    August 27, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Precision medicine,Technology and platforms

    Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France

    CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

    June 27, 2025
  • Cell & Gene Therapy,Regulatory Affairs

    UK experts urge Government to appoint Minister for cell and gene therapies

    Commission sets out 25 policy recommendations to unlock access and [...]

    June 23, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    Fujifilm life sciences companies rebrand to strengthen end-to-end drug development solutions

    Fujifilm Corporation’s Life Sciences Group has rebranded its key companies [...]

    June 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Trials

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 27, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Market Access & Commercialization

    Symbiosis passes MHRA audit at new sterile fill/finish site, expanding aseptic manufacturing capacity

    Symbiosis Pharmaceutical Services has completed a successful inspection by the [...]

    May 22, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials
    Categories: Artificial Intelligence, Clinical Trials, Diagnostics, Oncology
  • DFE Pharma launches EcoLact 2030 to cut CO₂ emissions across lactose excipients
    Categories: Ingredients, Manufacturing, Pharmaceuticals and therapeutics, Sustainability
  • Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Respiratory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top